Viewing Study NCT00687934

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2026-01-07 @ 6:57 AM
Study NCT ID: NCT00687934
Status: COMPLETED
Last Update Posted: 2014-09-18
First Post: 2008-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors
Sponsor: Synta Pharmaceuticals Corp.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic cancer View
None solid tumor View
None histologically or cytologically confirmed non-hematological View
None malignancy that is metastatic or unresectable for which no View
None standard therapy exists View
None STA-9090 View
None ganetespib View